Journal
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
Volume 2021, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2021/5536679
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81803988, 81760838, 81760808, 81460679]
- Natural Science Foundation of Jiangxi Province [20192ACB20015, 20181BAB205082, 20171BAB215057, 20171BAB205088]
- Education Department of Jiangxi Province [GJJ171542]
- Health and Family Planning Commission of Jiangxi Province [2018511, 20185510, 2017A248, 2017A279, 1141900603]
- First-Class Subjects Starting Funds [JXSYLXK-ZHYI022, JXSYLXK-ZHYAO132, JXSYLXK-ZHYAO108]
- Jiangxi University of Traditional Chinese Medicine
Ask authors/readers for more resources
Sishen Pill effectively treats chronic colitis by inhibiting activation of the Rho/ROCK signaling pathway through suppression of the PI3K/Akt signal to maintain intestinal mucosal barrier integrity.
Sishen Pill (SSP) is a classical prescription of traditional Chinese medicine and often used to treat gastrointestinal diseases, including ulcerative colitis (UC). However, its mechanism is still unclear. We aimed to determine the mechanism of SSP in the treatment of UC by investigating if it maintains the integrity of the intestinal mucosal barrier via the Rho A/Rho kinase (ROCK) signaling pathway. Administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS) successfully induced chronic UC in rats, while the treatment effect of SSP was evaluated by body weight change, colonic length, colonic weight, colonic weight index, histological injury score, and pathological injury score after colitis rats were treated for 7 days. TNF-alpha and IL-1 beta levels were analyzed by ELISA, and the proteins of PI3K/Akt and RhoA/ROCK signaling pathway and junction proteins expression were measured by western blotting assay, and the distribution of Claudin 5 was shown by immunofluorescence. SSP significantly improved the clinical symptoms of colitis in rats and reduced the expression of p-RhoA, ROCK1, PI3K, and Akt in the colon mucosa, while it increased the expression of p-Rac and related proteins (Claudin-5, JAM1, VE-cadherin, and Connexin 43). In addition, SSP increased p-AMPK alpha and PTEN proteins expression, decreased Notch1 level, and hinted that activation of the PI3K/Akt signaling pathway was inhibited. In conclusion, SSP effectively treated chronic colitis induced by TNBS, which may have been achieved by inhibiting PI3K/Akt signal to suppress activation of the Rho/ROCK signaling pathway to finally maintain the integrity of the intestinal mucosal barrier.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available